Skip to content

Developing novel oligonucleotide treatments

What we do Our primary project is a next generation topical treatment of eczema (atopic dermatitis) for mild to moderate symptoms

Non-invasive and easy application

Non-invasive and easy application

Regenerates tissue of the afflicted area

Regenerates tissue of the afflicted area

Saves vital immune defenses

Saves vital immune defenses

Anna-Lena Spetz Founder, Chief Scientific Officer

quote 2

There is a large unmet need for effective, non-steroid topical treatments for patients suffering from mild-moderate eczema, especially for children and young adults. TIRmed´s immunoregulatory cream has the potential to fill this gap

Latest News